ADHD and Depression Together: How Clinicians Decide What Comes First

When ADHD and depression occur together, clinicians generally treat the condition that is more severe, more impairing or less stable first. When depression is causing significant impairment, that usually means stabilizing mood first and reassessing attention once mood has improved. Anyone with suicidal thoughts needs safety addressed before any other step. When depression is mild and ADHD is the main source of impairment, treating ADHD first can be reasonable.

Before either step, a careful prescriber screens for bipolar disorder, because both antidepressants and ADHD medications can trigger mania in people at risk. The order is a clinical judgment you make with your prescriber, guided by safety first.

Why the order matters

Depression and ADHD share surface features: poor concentration, low motivation, unfinished tasks, restlessness or sluggishness, and disrupted sleep. A depressed adult can look inattentive on an ADHD checklist, and an adult with lifelong ADHD can become demoralized after years of missed deadlines and criticism. In the national survey behind the best-known estimate of adult ADHD in the United States, adult ADHD was highly comorbid with other psychiatric disorders, and most adults with ADHD were untreated for it.

Getting the sequence right helps in three ways. It protects safety when depression is severe. It avoids medication changes that are hard to interpret, because starting two drugs at once makes it impossible to tell which one helped or caused a side effect. And it gives each condition a fair test. Pediatric guidance reflects how often the two coexist: the American Academy of Pediatrics tells clinicians evaluating a child or teen for ADHD to at least screen for depression and other coexisting conditions.

Step one: a safety screen before any sequencing

Three questions come before "which first?"

• Is there suicidal thinking, self-harm or hopelessness? If so, mood and safety are the priority, with a written safety plan. The guide to safety planning for suicidal thoughts explains how one works.
• Is there any history of mania or hypomania, or a family history of bipolar disorder? The labels for bupropion and lisdexamfetamine both tell prescribers to screen for bipolar disorder or risk factors for mania before starting, and atomoxetine's label says the same. The site's post on how clinicians tell bipolar disorder from ADHD covers the overlap.
• Are there psychotic symptoms, heavy substance use or a medical cause? UK guidance advises stopping ADHD medication during an acute psychotic or manic episode and reconsidering it only after the episode resolves.

If you are thinking about suicide or are in crisis, call or text 988 (the 988 Suicide & Crisis Lifeline) or go to the nearest emergency room.

How clinicians usually sequence treatment

A 2025 review of adult ADHD with depression and anxiety summarizes the guideline consensus: prioritize the most severe, functionally impairing and unstable condition, then address the others in sequence. For ADHD with a mood disorder, it notes that stabilizing the mood disorder is typically prioritized, followed by reassessment of residual ADHD symptoms. The table translates that into common scenarios.

For people already taking ADHD medication, a depressive episode is a reason to review the whole plan with the prescriber, not to stop the ADHD medicine alone. For a deeper look at why the bipolar question matters, see bipolar depression treatment, where standard antidepressants are handled differently.

When depression is treated first

Depression treatment follows the same evidence base it would without ADHD: psychotherapy, antidepressant medication or both, chosen by severity and preference. The overview of depression treatment options and the guide to choosing a first antidepressant cover those choices.

All antidepressants carry a Boxed Warning: in short-term trials they increased the risk of suicidal thoughts and behavior in children, adolescents and young adults, and patients of all ages starting one should be monitored closely for worsening. The same label lists anxiety, agitation, insomnia, irritability, impulsivity and restlessness among symptoms families should watch for and report. Those overlap with ADHD symptoms, which is another reason to change one thing at a time.

Once mood has improved, the attention question gets a cleaner look. If concentration returns along with mood, the problem may have been depression all along. If lifelong inattention persists on a good day, an ADHD evaluation or ADHD treatment is the next step.

Bupropion: one medication for both?

Bupropion is often discussed for people with depression and ADHD symptoms, because its label describes it as a relatively weak inhibitor of norepinephrine and dopamine reuptake that does not affect serotonin reuptake. Its FDA status is specific. Wellbutrin XL is FDA-approved for major depressive disorder and for preventing seasonal depressive episodes in seasonal affective disorder. Use for ADHD is off-label: a Cochrane review notes bupropion is registered for depression and smoking cessation and is used off-label for ADHD.

The evidence for ADHD is modest. That review pooled 6 placebo-controlled trials with 438 adults and found low-quality evidence that bupropion reduced ADHD symptom severity and increased the share of people who improved, with tolerability similar to placebo. Several of those trials excluded people with other psychiatric conditions, so they say little directly about people who have depression as well.

Safety rules matter. Bupropion can cause seizures, the risk rises with dose, and it is contraindicated in people with a seizure disorder or a current or past diagnosis of bulimia or anorexia nervosa. Its label also calls for screening for bipolar disorder before starting and for checking blood pressure before and during treatment, because it can raise blood pressure. Whether bupropion makes sense, and whether it would be used alone or alongside an ADHD medication, is a decision for your prescriber.

When ADHD is treated first

When depression is mild, safety concerns are absent and the low mood clearly follows ADHD-related setbacks, treating ADHD first can lift both. Observational data offer some support for this idea: in a 10-year follow-up of boys with ADHD, those who had received stimulants were significantly less likely to develop later depressive and anxiety disorders. That was not a randomized trial, so it shows an association rather than proof.

Prescribers starting ADHD medication in someone with depressive symptoms take extra care. The lisdexamfetamine label lists comorbid or past depressive symptoms and a family history of suicide, bipolar disorder or depression as risk factors to screen for before treatment, because stimulants can induce a manic or mixed episode. UK guidance recommends slower dose titration and more frequent monitoring when ADHD coexists with depression or bipolar disorder. The comparison of stimulant and non-stimulant medication covers the classes in more detail.

Atomoxetine in ADHD with depression

Atomoxetine (Strattera) is FDA-approved for ADHD in adults and children 6 and older, not for depression. In a placebo-controlled trial in adolescents with both ADHD and major depression, atomoxetine improved ADHD symptoms but did not improve depression scores more than placebo. It carries a Boxed Warning about suicidal thoughts and behaviors in pediatric patients 6 and older. So it may help the attention side, but it should not be expected to treat depression on its own.

Therapy's role when both conditions are present

Medication sequencing gets most of the attention, but psychotherapy often does work that no single drug can. For depression, structured therapies such as cognitive behavioral therapy and behavioral activation target withdrawal, hopelessness and inactivity directly; the guide to behavioral activation describes one of the simplest. For ADHD, a randomized trial in adults whose symptoms persisted on medication found that CBT improved ADHD symptoms more than relaxation training with educational support, with gains maintained at 12 months. UK guidance suggests considering non-drug treatment for adults with ADHD who choose not to take medication, cannot tolerate it, or remain significantly impaired on it.

Therapy also helps with the sequencing itself. A therapist who sees you weekly often notices earlier than a prescriber whether low mood is lifting, whether restlessness is new, or whether concentration problems remain once mood improves. With your consent, that information can shape the next medication decision. Practical skills, such as breaking tasks into steps, using external reminders and scheduling rewarding activities, serve both conditions at once.

What the evidence does not show: there is little high-quality research testing one sequence against another in adults who have both conditions, so most recommendations rest on clinical consensus and safety logic rather than head-to-head trials. That is a good reason to treat the first plan as a hypothesis you test together, with a clear review date.

What monitoring should look like

Whatever comes first, agree on what you will track before you start. A simple shared record makes visits more useful than impressions from memory.

The guide to PHQ-9 and GAD-7 scores explains the most common mood questionnaires, and ongoing medication management covers how often follow-up visits usually happen.

A worked example

Consider a hypothetical college senior, an illustration rather than a real patient. He was diagnosed with ADHD in middle school and stopped treatment in high school. This term he is failing two classes, sleeping until noon, has lost interest in friends and says he feels like a burden.

• The words "feel like a burden" prompt a direct safety assessment and a safety plan before any medication decision.
• His prescriber treats the depression first, with therapy and an antidepressant, and asks his family about any history of bipolar disorder before choosing the medicine.
• Once his mood is clearly better, they revisit attention. His focus problems predate the depression and remain on good days, so they discuss restarting ADHD treatment, changing one medicine at a time.

If instead he had mild low mood that lifted on weekends and tracked his academic stress, starting with ADHD treatment and campus supports could have been a reasonable first step. The guide to mental health care for college students covers campus and telehealth options.

Questions to ask your clinician

• Which condition do you think is more impairing for me right now, and why?
• Have we ruled out bipolar disorder, and what in my history or family history matters?
• If we treat depression first, when will we reassess my attention?
• Is bupropion an option for me, and what does off-label use mean in my case?
• What should prompt me to call between visits?
• How will my therapist and prescriber share what they are seeing?

Do not start, stop or switch an antidepressant or ADHD medication on your own. Some of these medicines need to be tapered rather than stopped suddenly, and your prescriber can plan any change safely.

How Dr. Lewis's practice approaches ADHD with depression

The practice's team includes psychiatrists, psychiatric nurse practitioners and psychotherapists, and its care covers psychiatric evaluation and medication management, psychotherapy including CBT and DBT, and nutrition and lifestyle psychiatry. Its ADHD assessment uses a structured interview, rating scales that support but do not replace clinical diagnosis, and collateral history, followed by a written summary and treatment plan. If depression is severe or you are not safe, start with urgent care, then use the free discovery call to ask how ongoing care might work. The guide to choosing psychiatric care and the companion article on ADHD and anxiety are good next reads, along with the site's page on depression care.

Frequently asked questions

Can ADHD cause depression?

ADHD can contribute to depression through years of setbacks, criticism and stress, and the two often coexist. Depression can also arise independently. A clinician looks at timing and history to judge how they relate in your case.

Is bupropion FDA-approved for ADHD?

No. Bupropion (as Wellbutrin XL) is FDA-approved for major depressive disorder and for preventing seasonal depressive episodes. Its use for ADHD is off-label, supported by limited, low-quality trial evidence.

Can I take a stimulant and an antidepressant together?

Many people do, under one prescriber's supervision, but the combination needs a review of interactions, blood pressure and mood, and usually one change at a time. Ask your prescriber before adding either.

Will treating my depression fix my concentration?

Sometimes. Depression alone can impair focus, and attention often improves as mood lifts. If inattention dates back to childhood and persists when your mood is good, ADHD may also need treatment.

What if my ADHD medication seems to make me more depressed?

Tell your prescriber promptly rather than stopping on your own. Low mood, irritability or flat feelings can relate to dose, timing or wear-off, or to a separate depressive episode, and each has a different fix.

Does a teenager with ADHD and depression need a different approach?

The same principle applies: safety and mood first when depression is significant. Antidepressants carry a Boxed Warning about suicidal thoughts in young people, so monitoring is closer, and family involvement matters.

Sources

1. Adult ADHD and comorbid anxiety and depressive disorders: a review of etiology and treatment. Frontiers in Psychiatry (Fu et al.), doi:10.3389/fpsyt.2025.1597559, 2025. pmc.ncbi.nlm.nih.gov
2. Wellbutrin XL (bupropion hydrochloride extended-release) prescribing information. Bausch Health / DailyMed (NLM), 2026. dailymed.nlm.nih.gov
3. Bupropion for attention deficit hyperactivity disorder (ADHD) in adults. Cochrane Database of Systematic Reviews CD009504 (Verbeeck et al.), 2017. pubmed.ncbi.nlm.nih.gov
4. Strattera (atomoxetine) prescribing information. Eli Lilly and Company / DailyMed (NLM), 2026. dailymed.nlm.nih.gov
5. Efficacy and safety of atomoxetine in adolescents with attention-deficit/hyperactivity disorder and major depression. Journal of Child and Adolescent Psychopharmacology 17(4):407-20 (Bangs et al.), 2007. pubmed.ncbi.nlm.nih.gov
6. Vyvanse (lisdexamfetamine dimesylate) prescribing information. Takeda Pharmaceuticals / DailyMed (NLM), 2026. dailymed.nlm.nih.gov
7. Attention deficit hyperactivity disorder: diagnosis and management (NG87), Recommendations. National Institute for Health and Care Excellence (NICE), 2018, updated 2019. nice.org.uk
8. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. American Journal of Psychiatry 163(4):716-23 (Kessler et al.), 2006. pubmed.ncbi.nlm.nih.gov
9. Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents. American Academy of Pediatrics, Pediatrics 144(4):e20192528, 2019. pmc.ncbi.nlm.nih.gov
10. Do stimulants protect against psychiatric disorders in youth with ADHD? A 10-year follow-up study. Pediatrics 124(1):71-8 (Biederman et al.), 2009. pubmed.ncbi.nlm.nih.gov
11. Cognitive behavioral therapy vs relaxation with educational support for medication-treated adults with ADHD and persistent symptoms: a randomized controlled trial. JAMA 304(8):875-80 (Safren et al.), 2010. pubmed.ncbi.nlm.nih.gov

Educational information, not medical, tax or legal advice. Decisions about diagnosis, medication and treatment belong with a clinician who knows your history.